Astrea Bioseparations has launched its Nereus LentiHERO lentiviral vector (LVV) purification technology commercially. Incorporating AstreAdept, the company’s proprietary nanofiber material, this solution has been created to address the challenges associated with purifying the large and fragile products used in cell and gene therapy. AstreAdept is a proprietary bioseparations material that utilises nanofiber technology which enables […]
Menu ≡ ╳ 
